GlassScriptPhysician profile
Seung Kwon Lee
NPI 1700880267
$489.54
in general payments reported to CMS, 2019-2025
9 companies · $24.86 in 2025
The $24.86 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $282 · 2020: $62.18 · 2021: $120 · 2025: $24.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $24.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $24.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $142.59 | 2019 | |
| Nobel Biocare USA | $114.94 | 2021 | |
| Smith+Nephew, INC. | $90.01 | 2019 | |
| Kci USA, INC. | $30.83 | 2019 | |
| Organogenesis INC. | $28.52 | 2020 | |
| Mimedx Group, INC. | $24.86 | 2025 | |
| Medela LLC | $24.01 | 2020-2021 | |
| Osiris Therapeutics INC. | $18.95 | 2019 | |
| Integra Lifesciences Corporation | $14.83 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seung Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.